NIH-funded research R01 grant

Identifying imaging markers of nerve damage in multiple sclerosis

Official title: Toward a Validated in Vivo Imaging Marker of Axonal Damage Predictive of Progressive Disability in Multiple Sclerosis

Funded at Massachusetts General Hospital · NIH-11064891 · Data updated 2026-11-12

This study is looking at how we can see nerve damage in people with multiple sclerosis using special imaging techniques, which could help us track how the disease changes over time and how well new treatments are working.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 1, 2021
Project endMarch 31, 2026
Funding year2025
Award (this year)$516,993
NIH project number5R01NS118187-05
Project IDNIH-11064891 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with multiple sclerosis who are experiencing varying degrees of disability.

Less likely to help

Patients with other neurological conditions or those without a diagnosis of multiple sclerosis may not benefit from this research.

What this research studies

This research investigates how axonal damage, which is a key factor in the progression of multiple sclerosis (MS), can be detected using advanced imaging techniques. By employing high-gradient diffusion MRI, the study aims to visualize changes in axonal structure over time, particularly in relation to demyelination. The goal is to validate these imaging findings against tissue samples to better understand how nerve damage evolves in MS patients. This could lead to improved monitoring of disease progression and the effectiveness of new treatments.

Why it matters

Potential benefit: If successful, this research could provide a reliable imaging method to track nerve damage in MS, potentially leading to better treatment strategies.

How similar studies have gone: Previous research has shown promise in using advanced imaging techniques to assess axonal damage in MS, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Huang, Susie Yi — Massachusetts General Hospital
  • Study coordinator: Huang, Susie Yi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.